Market Currents
Amgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the development and...
-
Monday, April 2, 2012, 4:39 PM ETAmgen (AMGN) and AstraZeneca (AZN) have agreed to collaborate on the development and commercialization of 5 drugs in Amgen's clinical inflammation porfolio. AstraZeneca will lead the way in developing 3 of the 5 drugs. AstraZeneca will make a $50M one-time payment to Amgen, as well as royalty payments following commercialization.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment: